# Nasus Pharma Ltd. (NSRX)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NSRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | N/A | N/A | N/A | $ 1.80M | $ -3.21M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.56 |
| Liabilities / Eq | -1.22 |
| Current Ratio | 0.12 |

## Other views

- [Metrics](https://sponda.capital/en/NSRX.md)
- [Charts](https://sponda.capital/en/NSRX/charts.md)
- [Compare](https://sponda.capital/en/NSRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.